University of Worcester Worcester Research and Publications

Prodrug to Probe Solution HFA pMDI Formulation and Pulmonary Esterase Activity

Seville, Peter C. ORCID:, Simons, C., Taylor, G. and Dickinson, P.A. (2000) Prodrug to Probe Solution HFA pMDI Formulation and Pulmonary Esterase Activity. International Journal of Pharmaceutics, 195 (1-2). pp. 13-16. ISSN Print: 0378-5173 Online: 1873-3476

Full text not available from this repository. (Request a copy)


A novel salbutamol prodrug was synthesised. Solubility in HFA-134a and susceptibility to rat lung homogenate, blood and plasma esterase enzymes were investigated. Whereas salbutamol had a very low solubility in HFA-134a, the prodrug was found to be miscible in all proportions. In lung homogenate, the prodrug hydrolysed with a half-life of 45 min, re-generating approximately 17% of expected salbutamol after 8 h incubation. The use of a solution pMDI for pulmonary delivery of the salbutamol prodrug is predicted to result in liberation of salbutamol in the lungs following in vivo hydrolysis by lung esterases.

Item Type: Article
Additional Information:

The full-text of the published version cannot be supplied. Please check availability with your local library or Interlibrary Requests service.

Uncontrolled Discrete Keywords: salbutamol, ester, prodrug, solution, inhaler, lung
Divisions: College of Health, Life and Environmental Sciences > School of Science and the Environment
Related URLs:
Depositing User: Peter Seville
Date Deposited: 17 Jun 2019 09:41
Last Modified: 17 Jun 2020 17:30

Actions (login required)

View Item View Item
Worcester Research and Publications is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.